Compare
Tactile Systems Technology Inc vs Angiodynamics Inc vs PROCEPT BioRobotics Corp vs Accuray Inc
| Latest fiscal year | Tactile Systems Technology Inc TCMD | Angiodynamics Inc ANGO | PROCEPT BioRobotics Corp PRCT | Accuray Inc ARAY |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-05-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $329.52M | $320.17M | $308.05M | $401.95M |
| Revenue growth (YoY) | +12.5% | +9.5% | +37.2% | -12.3% |
| Gross margin | 75.9% | 54.6% | 63.7% | 27.7% |
| Operating margin | 8.9% | -12.5% | -33.7% | -6.6% |
| Net margin | 5.8% | -11.5% | -31.0% | -12.2% |
| Net income | $19.09M | -$36.74M | -$95.57M | -$49.19M |
| EPS (Diluted) | $0.82 | -$0.88 | -$1.72 | n/a |
| Operating cash flow | $42.81M | $3.09M | -$48.98M | -$6.98M |
| Free cash flow | $40.43M | $508.0K | -$58.34M | -$12.84M |
| Cash & equivalents | $83.45M | $53.86M | $286.50M | $40.62M |
| Total assets | $273.94M | $267.16M | $508.08M | $443.68M |
| Total liabilities | $55.04M | $96.34M | $142.21M | $401.98M |
| Shareholders' equity | $218.90M | $170.82M | $365.87M | $41.70M |
| Return on year-end equity | 8.7% | -21.5% | -26.1% | -118.0% |
| Shares outstanding | 22.44M | 41.70M | 56.32M | 119.43M |
Revenue, most recent five fiscal years
| Fiscal year | Tactile Systems Technology Inc | Angiodynamics Inc | PROCEPT BioRobotics Corp | Accuray Inc |
|---|---|---|---|---|
| Latest | $329.52M Ended 2025-12-31 | $320.17M Ended 2026-05-31 | $308.05M Ended 2025-12-31 | $401.95M Ended 2026-06-30 |
| 1 year earlier | $292.98M Ended 2024-12-31 | $292.50M Ended 2025-05-31 | $224.50M Ended 2024-12-31 | $458.50M Ended 2025-06-30 |
| 2 years earlier | $274.42M Ended 2023-12-31 | $303.91M Ended 2024-05-31 | $136.19M Ended 2023-12-31 | $446.55M Ended 2024-06-30 |
| 3 years earlier | $246.78M Ended 2022-12-31 | $338.75M Ended 2023-05-31 | $75.01M Ended 2022-12-31 | $447.61M Ended 2023-06-30 |
| 4 years earlier | $208.06M Ended 2021-12-31 | $316.22M Ended 2022-05-31 | $34.47M Ended 2021-12-31 | $429.91M Ended 2022-06-30 |